New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:01 EDTCRMECardiome announces commercializatoin partnership for Aggrastat
Cardiome announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize Aggrastat in selected European markets. AOP Orphan will be responsible for the commercialization of Aggrastat in the AOP Orphan countries. Under terms of the agreement, AOP Orphan has agreed to specific annual commercial goals for Aggrastat. Financial details of the agreement were not disclosed.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
08:24 EDTCRMECardiome enters development, commercialization agreement with Eddingpharm
Cardiome Pharma announced that one of its subsidiaries has entered into an agreement with Eddingpharm to develop and commercialize BRINAVESS in China, Taiwan, and Macau and re-launch BRINAVESS in Hong Kong. Eddingpharm will be responsible for any clinical trials and regulatory approvals required to commercialize BRINAVESS in the countries covered by the agreement. Under the terms of the agreement, Eddingpharm has agreed to an upfront payment of $1.0M and specific annual commercial goals for BRINAVESS. Cardiome is also eligible to receive regulatory milestone payments of up to $3.0M. Other financial details have not been disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use